Novo raises full-year outlook as Wegovy pill sales impress

Novo Nordisk reported quarterly earnings that exceeded analyst expectations, with Wegovy pill sales surpassing forecasts. The company raised its full-year outlook following the results. Novo released the financial report on Wednesday.

• CNBC — Novo raises full-year outlook as Wegovy pill sales impress

Next story